Alnylam Pharmace Dl 0001 (DUL)
TG
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 89.91M | 74.91M | 219.75M | 492.85M | 844.29M | 1.04B | 1.83B | 2.25B |
| Operating Income | -500.09M | -814.67M | -939.43M | -828.44M | -708.65M | -785.07M | -282.18M | -176.89M |
| Pre Tax Income | -490.87M | -760.67M | -885.25M | -855.6M | -852.14M | -1.13B | -433.52M | -377.38M |
| Net Income | -490.87M | -761.5M | -886.12M | -858.28M | -852.82M | -1.13B | -440.24M | -278.16M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -4.925 | -7.526 | -7.898 | -7.372 | -7.096 | -9.128 | -3.508 | -2.157 |
| EBIT | -503.11M | -789.94M | -918.7M | -782.91M | -727.96M | -791.28M | -407.86M | -183.72M |
| EBITDA | -488.19M | -801.87M | -922.83M | -798.24M | -661.09M | -740.6M | -228.12M | -120.22M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
